Letters to the Editor
Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry
R. Faraawi1, A. Chow2, M. Khraishi3, D. Haaland4, F. Nantel5, B. Osborne6
- McMaster University, Hamilton, ON, Canada.
- Credit Valley Rheumatology, University of Toronto, ON, Canada.
- Nexus Clinical Research, St. John’s, NF, Canada.
- McMaster University, Hamilton, ON, Canada.
- Janssen Inc., Toronto, ON, Canada.
- Janssen Inc. Toronto, ON, Canada. bosborn4@its.jnj.com
CER11826
2020 Vol.38, N°2
PI 0371
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 31820720 [PubMed]
Received: 16/10/2018
Accepted : 04/08/2019
In Press: 18/11/2019
Published: 26/03/2020
